A High-Throughput and Logarithm-Serial-Dilution Microfluidic Chip for Combinational Drug Screening on Tumor Organoids
ACS Pharmacology & Translational Science · 13.12.2024 · 7 (12) · 4135-4143
DOI: 10.1021/acsptsci.4c00565 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 04.12.2024. Verfasst von Xingyang Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon 999077, Hong Kong, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Research Grants Council, University Grants Committee, Basic and Applied Basic Research Foundation of Guangdong Province, Innovation and Technology Commission.
Abstract (Originalsprache)
Tumor organoids are biological models for studying precision medicine. Microfluidic technology offers significant benefits for high throughput drug screening using tumor organoids. However, the range of concentrations achievable with traditional linear gradient generators in microfluidics is restricted, generating logarithmic drug concentration gradients by adjusting the channel ratio in the chip is confined to single-drug dilution chips, significantly restricting the application of microfluidics in drug screening. Here, we presented a microfluidic chip featuring continuous dilution capabilities, which generates logarithmic stepwise drug concentration gradients. We have devised a "mathematical-circuit-chip" model for designing such chips, and based on this model, we have developed and fabricated a device capable of providing 36 distinct drug concentration conditions for two types of drugs. The chip is composed of two structurally identical yet orthogonally arranged layers, each containing a dilution network capable of forming a 5-fold gradient and a tumor organoid culture module. Drug and culture medium delivery to the open culture chamber array is driven by syringe pumps. We have conducted drug screening experiments on patient-derived tumor organoids. This device facilitates high-throughput drug screening for patient-derived organoids, representing a significant stride toward the realization of precision medicine.
Autor:innen und Institutionen
- Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon 999077, Hong Kong, China.
- Department of Biology, Southern University of Science and Technology, Shenzhen 518055, Guangdong, China.
- Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- Department of Urology, Shenzhen Institute of Translational Medicine, Shenzhen Institutes of Advanced Technology, The First Affiliated Hospital of Shenzhen University, International Cancer Center of Shenzhen University,…
- The Hong Kong University of Science and Technology Shenzhen Research Institute, Shenzhen 518172, China.
ORCID-Profile: Xingyang Yan, Hongkai Wu
Förderung
- Research Grants Council, University Grants Committee
- Basic and Applied Basic Research Foundation of Guangdong Province
- Innovation and Technology Commission
- Hong Kong University of Science and Technology
Zitieren
APA
Yan, X., Tan, D., Yu, L., Li, D., Huang, W., Huang, W., & Wu, H. (2024). A High-Throughput and Logarithm-Serial-Dilution Microfluidic Chip for Combinational Drug Screening on Tumor Organoids. ACS Pharmacology & Translational Science, 7(12), 4135-4143. https://doi.org/10.1021/acsptsci.4c00565
Vancouver
Yan X, Tan D, Yu L, Li D, Huang W, Huang W, et al. A High-Throughput and Logarithm-Serial-Dilution Microfluidic Chip for Combinational Drug Screening on Tumor Organoids. ACS Pharmacology & Translational Science. 2024;7(12):4135-4143. doi:10.1021/acsptsci.4c00565
BibTeX
@article{Yan2024,
author = {Yan, Xingyang and Tan, Deng and Yu, Lei and Li, DanYu and Huang, Wei and Huang, Weiren and Wu, Hongkai},
title = {A High-Throughput and Logarithm-Serial-Dilution Microfluidic Chip for Combinational Drug Screening on Tumor Organoids},
journal = {ACS Pharmacology & Translational Science},
year = {2024},
volume = {7},
number = {12},
pages = {4135--4143},
doi = {10.1021/acsptsci.4c00565}
}
EUVIMED